mortality/aging
• accelerated disease progression
• shorter lifespans than Tg(SOD1*G93A)1Gur and Tg(SOD1*G93A)1Gur, Tcrbtm1Mom heterozygous mice
|
growth/size/body
weight loss
(
J:143173
)
• accelerated weight loss after disease onset compared to Tg(SOD1*G93A)1Gur, Tcrbtm1Mom heterozygous littermates, mainly after day 135
|
nervous system
• decreased microglia reactivity
|
• accelerated disease progression
• motor neuron loss in spinal cords earlier at day 140
• accelerated motor decline after disease onset compared to Tg(SOD1*G93A)1Gur, Tcrbtm1Mom heterozygous littermates, mainly after day 135
|
immune system
• decreased microglia reactivity
|
hematopoietic system
• decreased microglia reactivity
|